OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Cardiology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Knowing More Than the Knowns in Familial Hypercholesterolemia	442
Error in Table 1	269
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	258
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	255
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	226
Primary Prevention Management of Elevated Lipoprotein(a)	215
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	182
A Woman With Recurrent Torsade de Pointes	179
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	168
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	168
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	160
Chest Pain in a Middle-Aged Man	154
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	152
Genome-Wide Association Study of Accessory Atrioventricular Pathways	152
JAMA Cardiology	150
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	145
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	142
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	137
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	134
Midlife Wealth Mobility and Long-term Cardiovascular Health	126
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	126
JAMA Cardiology	118
USPSTF Report on Aspirin for Primary Prevention	115
Accountable Care Organization Participation and Cardiovascular Care Quality	115
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	101

Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	100
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	100
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	98
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	97
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	93
JAMA Cardiology	92
What Is Your Secret to Health?	91
Supraventricular Tachycardia Following Mitral Valve Surgery	89
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	89
Assessing Performance of Machine Learning—Reply	88
JAMA Cardiology	86
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	83
Contribution of Clinical Trial Event Data by Data Source	82
Hypertriglyceridemia in the MESA Study—Reply	82
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	81
User Trust in Artificial Intelligence–Guided Lung Ultrasound	80
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	78
Innovation in Event Adjudication—Human vs Machine	78
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	78
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	78
Transthyretin Cardiac Amyloidosis in the Elderly—Tip of a Heart Failure Iceberg?	77
Peak Oxygen Uptake vs Ventilatory Efficiency	77
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	76
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	74
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	74
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	74
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	74
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	73
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	72
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	70
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	68
Change to Open Access Status	66
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	66
Corrected to Open Access Status	66
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	64
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	63
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	63
PCSK9 in Familial Hypercholesterolemia and Beyond	63
JAMA Cardiology	62
Error in Figure	60
Young Man With Coarctation of the Aorta	60
JAMA Cardiology	58
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	57
An Expanded Heart Failure Indication for Sacubitril/Valsartan	57
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	57
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors	57
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	56
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	55
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	55
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	55

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis	53
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	53
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	53
Exercise Capacity in Young Adults Born Small for Gestational Age	53
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	53
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	53
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	52
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	52
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	52
Passing the Stethoscope	51
To Occlude or Not to Occlude the Left Atrial Appendage in Women	50
JAMA Cardiology	50
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	50
A Woman With Syncope and Frequent Premature Ventricular Contractions	50
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	49
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	49
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	49
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	49
Error in Figure 1	48
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	48
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	46
Error in Abstract and Results	46
Troponins and Pregnancy—Reply	45
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	45
Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications	45
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	44
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	44
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	43
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	43
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	43
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	43
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	43
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	42
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	42
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	42
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	42
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	42
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	40
When Is a Placebo Not a Placebo	40
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	40
Preserving and Promoting Clinical Trial Representativeness	40
Personalizing Risk for Sudden Cardiac Death Among Patients With Dilated Cardiomyopathies	39
Early Mortality in Type A Acute Aortic Dissection	39
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	38
A Patient in Their 30s With Dyspnea and a Spongy Heart	38
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	38
Incidental Complication From a Left Atrial Appendage Device	37
An Elderly Woman With Ventricular Tachycardia	37
Myocardial Infarction and Evolocumab	37
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	37
In Honor of the Pig	36
My Grandfather’s Blueprint	36
Expanding Discovery in Cardiovascular Genome-Wide Association Studies	36
JAMA Cardiology	36
JAMA Cardiology	35
Errors in Key Points, Abstract, Results, and Figures	35
JAMA Cardiology	35
Corrected to Open Access Status	34
Error in Abstract	34
Error in Table	34
Reflections of an Editorial Fellow—A Window Into Medical Publishing	34
State of the Nation’s Cardiovascular Health and Targeting Health Equity in the United States	34
Errors in Author Affiliations and Open Access Updated	34
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	34
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	33
The Limitations and Risks Associated With Semaglutide Treatment—Reply	33
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	33
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	33
Finerenone in Heart Failure—Reply	33
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	32
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017	32
The Last Mile in Prevention—Can Coronary CT Angiography Help?	32
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	32
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	32
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	32
Preventing Declines in Cardiovascular Health From Childhood	32
PREVENT Risk Age Equations and Population Distribution in US Adults	32
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	31
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk	31
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	31

Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	31
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	31
Error in Corresponding Author Information	31
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	30
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	30
JAMA Cardiology	30
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	30
Updated USPSTF Guidelines for Screening for Atrial Fibrillation	29
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	29
Moving Beyond Conventional Guesstimation to Guide PCI	29
Medicine, Writing, and the Limits of Language	29
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	29
A Young Woman With Dyspnea During Cardiac Catheterization	29
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	29
Dapagliflozin—Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?	29
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	28
Comment on Aspirin Avoidance in Patients With LVADs	28
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	28
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	27
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	27
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	27
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	27
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	27
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	27
Troubleshooting CardioMEMS After Implant—Failure to Read	26
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	26
JAMA Cardiology	26
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	26
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	26
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	26
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	26
A Teenager With Palpitations	25
Patient Enrollment for Cardiovascular Clinical Trials in the United States	25
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	25
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	25
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	24
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	24
JAMA Cardiology	24
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	23
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	23
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	23
The Fine Art and Science of Translating Trials Results Into Clinical Practice	23
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	23
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	23
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	23
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	23
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	22
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	22
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	22
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	22
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	22
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	22
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging	22
Transient Monocular Blindness in a Man in His 30s	21
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient	21
Authenticity—An Uphill Battle for a Black Woman in Cardiology	21
Blood Pressure Control After SPRINT—Back to Reality	21
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	21
Error in Affiliations	21
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	20
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	20
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	20
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Women’s Representation in Interventional Cardiology	20
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	20
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	20
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	20
Error in Abstract and Methods	20
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	20
Genetic Testing in Early-Onset Atrial Fibrillation	20
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	19
Long-term Survival After Out-of-Hospital Cardiac Arrest	19
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	19
Educational Attainment and Lifetime Risk of Cardiovascular Disease	19
Variants at the Interleukin 1 Gene Locus and Pericarditis	19
Private Equity and Cardiovascular Health Care	19
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	19
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	19
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	19
Heart Failure—Together We Go Farther—Reply	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Omitted Affiliation	18
Error in the First Paragraph	18
Errors in Abstract	18
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery	18
Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart	17
Social Vulnerability and Poor Health Outcomes	17
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy	17
Echoes of Concern—AI and Moral Agency in Medicine	17
Exercise-Induced Dyspnea in an Older Woman With a History of Coronary Artery Disease	17